Medicine & Health

Abhinav Jha and a group of interdisciplinary collaborators have developed a method to measure dopamine transporter, a protein related to movement and Parkinson’s disease.

Washington University School of Medicine faculty members Opeolu M. Adeoye, MD, Farshid Guilak, PhD, David H. Gutmann, MD, PhD, and Jonathan Kipnis, PhD, have been elected to the National Academy of Medicine, a part of the National Academy of Sciences. Membership is considered one of the highest honors in the health and medicine fields.

A $314,807 grant from the National Institutes of Health (NIH) will support Abhinav Jha’s interdisciplinary work looking at the ethics of artificial intelligence implementation in the medical sphere.

Washington University has licensed the rights to develop, manufacture and commercialize its proprietary COVID-19 nasal vaccine in the United States, Europe and Japan to Ocugen Inc., a U.S.-based biotechnology company.

Pioneering research at Washington University helped people understand the fundamental role of gut microbes in human health and disease. Now a community of local scientists is learning more about the diverse microbial systems that support animals, plants and ecosystems.

An award from Wellcome Leap will support Michelle Oyen’s study of fetal growth restriction during gestational development. The program aims to reduce stillbirth rates by half.

An international phase 3 clinical trial for a drug developed to treat a rare, inherited form of amyotrophic lateral sclerosis (ALS) showed that it reduced molecular signs of the fatal disease, but at six months did not improve motor control and muscle strength, according to Washington University School of Medicine researchers.

St. Louis CITY Soccer Club has chosen physicians with Washington University Orthopedics as the club’s official team doctors and BJC HealthCare as medical services provider.

Washington University School of Medicine is joining the National Institutes of Health (NIH)’s Bridge2AI program, an estimated $130 million initiative. One project aims to develop a framework for using artificial intelligence to diagnose disease based on the sound of patients’ voices.

To develop guidelines to evaluate artificial intelligence (AI) in nuclear-medicine imaging, an interdisciplinary team established by Richard L. Wahl, MD, director of Mallinckrodt Institute of Radiology (MIR) and led by Abhinav Jha, assistant professor at the McKelvey School of Engineering, published Recommendations for Evaluation of AI for Nuclear Medicine in the Journal of Nuclear Medicine.